Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows from Operating Activities:
Net Loss	$ (2,828,318)	$ (1,267,184)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization	21,924	22,467
Stock-based compensation	183,667	0
Changes in assets and liabilities:
Prepaid expenses and other receivables	(236,976)	(63,405)
Accounts payable	155,286	(15,355)
Liability due to related party	359,842	77,654
Other liabilities and accrued expenses	(44,318)	43,223
Accrued interest receivable	70,527	(58,504)
Net cash used in operating activities	(2,318,366)	(1,261,104)
Cash Flows from Investing Activities:
Capitalized patent costs	(13,844)	(29,732)
Purchase of property and equipment	(43,216)	0
Fixed rate savings account	4,469,150	1,955,489
Net cash provided by investing activities	4,412,090	1,925,757
Cash Flows from Financing Activities
Cash costs incurred in relation to ATM financing	(121,880)	0
Cash costs incurred in relation to public offering	(217,922)	0
Gross proceeds from issuance of common stock in relation to ATM financing	455,105	0
Gross proceeds from public offering	2,019,743	0
Gross proceeds from warrant exercise/unit option purchase	600	0
Net cash provided by financing activities	2,135,646	0
Net increase in cash	4,229,370	664,653
Effect of exchange rate changes on cash	(11,044)	88,604
Cash at beginning of period	822,335	911,359
Cash at end of period	5,040,661	1,664,616
Supplemental disclosure of non-cash financing activities:
Conversion of Series A preferred stock to common stock	137,324	0
Accrual of costs incurred in connection with the issuance of equity	$ 149,644	$ 0